34
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Synergistic anticholinergic and antiserotonergic effects in humans

, , , , &
Pages 611-621 | Accepted 15 Jan 1995, Published online: 04 Jan 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Peter H. Boeijinga. (2002) Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers. Dialogues in Clinical Neuroscience 4:4, pages 388-394.
Read now

Articles from other publishers (19)

Michal Weitman, Arik Eisenkraft, Zeev TaShma, Igor Makarovsky, David Last, Dianne Daniels, David Guez, Ran Shneor, Yael Mardor, Abraham Nudelman & Amir Krivoy. (2022) Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote. Scientific Reports 12:1.
Crossref
Rebecca Coray & Boris B. Quednow. (2022) The role of serotonin in declarative memory: A systematic review of animal and human research. Neuroscience & Biobehavioral Reviews 139, pages 104729.
Crossref
Daniel C. Javitt, Steven J. Siegel, Kevin M. Spencer, Daniel H. Mathalon, L. Elliot Hong, Antigona Martinez, Cindy L. Ehlers, Atheir I. Abbas, Tobias Teichert, Peter Lakatos & Thilo Womelsdorf. (2020) A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology. Neuropsychopharmacology 45:9, pages 1411-1422.
Crossref
PRA Heckman, A Blokland & A Sambeth. (2018) No interaction between rivastigmine and citalopram on memory and novelty processing in healthy human volunteers. Journal of Psychopharmacology 33:2, pages 210-218.
Crossref
S. Caldenhove, L.G.J.M. Borghans, A. Blokland & A. Sambeth. (2017) Role of acetylcholine and serotonin in novelty processing using an oddball paradigm. Behavioural Brain Research 331, pages 199-204.
Crossref
Amit Reches, Naama Levy-Cooperman, Ilan Laufer, Revital Shani-Hershkovitch, Keren Ziv, Dani Kerem, Noga Gal, Yaki Stern, Guy Cukierman, Myroslava K. Romach, Edward M. Sellers & Amir B. Geva. (2014) Brain Network Activation (BNA) Reveals Scopolamine-Induced Impairment of Visual Working Memory. Journal of Molecular Neuroscience 54:1, pages 59-70.
Crossref
Yu-San Chang, Hsiang-Lan Chen, Chung-Yao Hsu, Shu-Hui Tang & Ching-Kuan Liu. (2014) Parallel Improvement of Cognitive Functions and P300 Latency Following Donepezil Treatment in Patients With Alzheimer's Disease. Journal of Clinical Neurophysiology 31:1, pages 81-85.
Crossref
Inge Klinkenberg, Arjan Blokland, Wim J. Riedel & Anke Sambeth. (2012) Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants. Psychopharmacology 225:4, pages 903-921.
Crossref
Inge Klinkenberg & Arjan Blokland. (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neuroscience & Biobehavioral Reviews 34:8, pages 1307-1350.
Crossref
Bryon Adinoff, Michael D DevousSrSr, Mark J Williams, Susan E Best, Thomas S Harris, Abu Minhajuddin, Tanya Zielinski & Munro Cullum. (2010) Altered Neural Cholinergic Receptor Systems in Cocaine-Addicted Subjects. Neuropsychopharmacology 35:7, pages 1485-1499.
Crossref
Brandon A. Ally, Gary E. Jones, Jack A. Cole & Andrew E. Budson. (2006) The P300 component in patients with Alzheimer's disease and their biological children. Biological Psychology 72:2, pages 180-187.
Crossref
Eero Pekkonen, Iiro P. Jääskeläinen, Seppo Kaakkola & Jyrki Ahveninen. (2005) Cholinergic modulation of preattentive auditory processing in aging. NeuroImage 27:2, pages 387-392.
Crossref
Sandra L. Morzorati & Robert B. Stewart. (2006) Development of Acute Tolerance During Steady‐State Arterial Alcohol Concentrations: A Study of Auditory Event‐Related Potentials in Rats. Alcoholism: Clinical and Experimental Research 29:3, pages 347-352.
Crossref
Ulrike Ebert, Matthias Grossmann, Reinhard Oertel, Thomas Gramatté & Wilhelm Kirch. (2001) Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effects of Scopolamine in Healthy Volunteers. The Journal of Clinical Pharmacology 41:1, pages 51-60.
Crossref
M Hansenne. (2000) Le potentiel évoqué cognitif P300 (I) : aspects théorique et psychobiologique. Neurophysiologie Clinique/Clinical Neurophysiology 30:4, pages 191-210.
Crossref
D.C Javitt, M Jayachandra, R.W Lindsley, C.M Specht & C.E Schroeder. (2000) Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clinical Neurophysiology 111:5, pages 833-836.
Crossref
M. Hansenne & M. Ansseau. (2020) Potencial evocado cognitivo P300 y actividad del receptor 5-HT1A en la depresión. European psychiatry (Ed. Española) 7:1, pages 46-51.
Crossref
M Hansenne & M Ansseau. (2020) P300 event-related potential and serotonin-1A activity in depression. European Psychiatry 14:3, pages 143-147.
Crossref
Ebert & Kirch. (2001) Scopolamine model of dementia: electroencephalogram findings and cognitive performance. European Journal of Clinical Investigation 28:11, pages 944-949.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.